NeuroMetrix, Inc. Common Stock

electroCore, Inc. has completed the acquisition of NeuroMetrix, Inc., gaining access to the Quell platform and positioning itself as a leader in non-invasive bioelectronic technologies for chronic pain and wellness markets.

Related tickers: ECOR, NURO.

The global electrotherapy system market is expected to grow from $1.15 billion in 2023 to $1.65 billion by 2030, driven by advancements in technology and increasing demand for non-invasive treatment options. The TENS segment dominates the market, particularly for chronic pain management.

Related tickers: ABT, BSX, DYNT, LIVN, MDT, NURO, NVRO, ZYXI.